NAVIFY® Infection Management*

Powered by Innovaccer

Greetings from the future of healthcare.

Roche at ViVE 2022 : Shaping the future of tech-enabled healthcare

Roche welcomes thought leaders from across the healthcare ecosystem to ViVE 2022. We invite all attendees, including C-suite executives, experts in digital health, authorities on health startups and industry investment trends, and experienced government and regulatory professionals to learn how our versatile digital solutions are solving problems for healthcare providers and organizations, enabling more effective collaboration and patient-centered care.

The costly burden of acute infections

Across the U.S. healthcare system, prolonged length of stay and readmissions are persistent problems in managing many different diseases, with cardiovascular diseases and infections among the key driving factors:

Supporting statistics on infection management

By operating at the enterprise level,* our customizable digital platform helps improve the quality of care for diseases across the healthcare continuum, addressing three specific areas:

  • Hospital analytics—measuring and tracking operational, financial and clinical KPIs
  • In-hospital care navigation—focusing on length-of-stay, readmissions and adherence to clinical guidelines
  • Remote patient monitoring—helping reduce readmissions and costs through surveillance to detect adverse changes in a patient’s condition

Learn more about our ground-breaking digital solution that enables multidisciplinary teams to master key steps in proactive infection management to improve the patient’s experience and clinical outcomes.

Find out more about the Roche and Innovaccer collaboration in clinical decision support.

Register today to meet our team in person

Find us at booth number 732 on Level 1: Halls A-D

Roche booth at ViVE

* Product in development and not commercially available

1Centers for Disease Control and Prevention (2022) Sepsis Clinical Information. [online] Available at: [Accessed 2022-02-09]., ‘Largest Study of Sepsis Cases among Medicare Beneficiaries Finds Significant Burden’ (2020-02-14), available at: [accessed 2022-02-09]

3Masterson, L. (2017) ‘Sepsis costs Medicare $6B, topping all other inpatient discharges,’ [online] Healthcare Dive, Available at: [accessed 2022-02-09]

4Weinreich et al (2016) ‘Predicting the Risk of Readmission in Pneumonia. A Systematic Review of Model Performance,’ Annals of the American Thoracic Society,, available at: [accessed 2022-02-09]

 5Centers for Disease Control and Prevention (2021), ‘Million Hearts® Costs & Consequences,’ [online] available at: [Accessed 2022-02-09]

6Magill SS, O’Leary E, Ray SM, et al. (2021), ‘Assessment of the Appropriateness of Antimicrobial Use in US Hospitals,’ JAMA Netw Open, 4(3):e212007, doi:10.1001/jamanetworkopen.2021.2007

7SShahzeb et al, (2021), ‘Trends in 30- and 90-Day Readmission Rates for Heart Failure,’ [online] Circulation: Heart Failure. available at: [accessed 2022-02-09]